Document:

Exhibit

Exhibit 10.1

CORPORATE INTEGRITY AGREEMENT  
BETWEEN THE  
OFFICE OF INSPECTOR GENERAL  
OF THE  
DEPARTMENT OF HEALTH AND HUMAN SERVICES  
AND  
ENVISION HEALTHCARE CORPORATION
I.PREAMBLE 
Envision Healthcare Corporation (Envision) hereby enters into this Corporate Integrity Agreement (CIA) with the Office of Inspector General (OIG) of the United States Department of Health and Human Services (HHS) to promote compliance with the statutes, regulations, and written directives of Medicare, Medicaid, and all other Federal health care programs (as defined in 42 U.S.C. § 1320a-7b(f)) (Federal health care program requirements). Contemporaneously with this CIA, Envision is entering into a Settlement Agreement with the United States.
For the purpose of this CIA, “Envision” shall cover the following: Envision Healthcare Corporation and its directly or indirectly owned or controlled subsidiaries and affiliates that contract with hospitals to staff and manage either the hospitals’ emergency departments and/or the hospitals’ hospitalist programs, which currently includes (1) EmCare, Inc., its subsidiaries and affiliates that contract with hospitals to staff and manage either the hospitals’ emergency departments and/or the hospitals’ hospitalist programs (EmCare) and (2) Sheridan Healthcare, its subsidiaries and affiliates that contract with hospitals to staff and manage either the hospitals’ emergency department and/or the hospitals’ hospitalist programs (“Sheridan”) and (3) and any physician practice that is managed by Envision or any of its directly or indirectly owned or controlled subsidiaries or affiliates (including, but not limited to EmCare and Sheridan) that furnishes emergency department and/or hospitalist services.
II.TERM AND SCOPE OF THE CIA
A.    The period of the compliance obligations assumed by Envision under this CIA shall be five years from the effective date of this CIA. The “Effective Date” shall be the date on which the final signatory of this CIA executes this CIA. Each one-year period, beginning with the one-year period following the Effective Date, shall be referred to as a “Reporting Period.”

Envision Corporate Integrity Agreement 1

B.Sections VII, X, and XI shall expire no later than 120 days after OIG’s receipt of: (1) Envision’s final annual report; or (2) any additional materials submitted by Envision pursuant to OIG’s request, whichever is later.
C.The scope of this CIA shall be governed by the following definitions:
1.“Arrangements” shall mean every arrangement or transaction that:
involves, directly or indirectly, the offer, payment, solicitation, or receipt of anything of value; and is between Envision and any actual or potential source of health care business or referrals to Envision or any actual or potential recipient of health care business or referrals from Envision. The term “source of health care business or referrals” shall mean any individual or entity that refers, recommends, arranges for, orders, leases, or purchases any good, facility, item, or service for which payment may be made in whole or in part by a Federal health care program and the term “recipient of health care business or referrals” shall mean any individual or entity (1) to whom Envision refers an individual for the furnishing or arranging for the furnishing of any item or service, or (2) from whom Envision purchases, leases or orders or arranges for or recommends the purchasing, leasing, or ordering of any good, facility, item, or service for which payment may be made in whole or in part by a Federal health care program; or
2.“Focus Arrangements” means every Arrangement that:
is between Envision and a hospital that has an agreement with Envision to provide services payable by Federal health care programs.
3.“Covered Persons” includes:
		
	a.
	all owners who are natural persons (other than shareholders who: (1) have an ownership interest of less than 5% and (2)

Envision Corporate Integrity Agreement 2

acquired the ownership interest through public trading), officers, directors, and employees of Envision; and
		
	b.
	all contractors, subcontractors, agents, and other persons who furnish patient care items or services or who perform billing or coding functions on behalf of Envision excluding vendors whose sole connection with Envision is selling or otherwise providing medical supplies or equipment to Envision.

Notwithstanding the above, this term does not include part-time or per diem employees, contractors, subcontractors, agents, and other persons who are not reasonably expected to work more than 160 hours during a Reporting Period, except that any such individuals shall become “Covered Persons” at the point when they work more than 160 hours during a Reporting Period.
4.    “Arrangements Covered Persons” includes each Covered Person who is involved with the development, approval, management, or review of Envision’s Arrangements.
III. CORPORATE INTEGRITY OBLIGATIONS
Envision shall establish and maintain a Compliance Program that includes the following elements:
A.    Compliance Officer and Committee
1.    Compliance Officer. Within 90 days after the Effective Date, Envision shall appoint a Compliance Officer and shall maintain a Compliance Officer for the term of the CIA. The Compliance Officer shall be an employee and a member of senior management of Envision, shall report directly to the Chief Executive Officer of Envision, and shall not be or be subordinate to the General Counsel or Chief Financial Officer or have any responsibilities that involve acting in any capacity as legal counsel or supervising legal counsel functions for Envision. The Compliance Officer shall be responsible for, without limitation:
		
	a.
	developing and implementing policies, procedures, and practices designed to ensure compliance with the requirements set forth in this CIA and with Federal health care program requirements;

Envision Corporate Integrity Agreement 3

		
	b.
	making periodic (at least quarterly) reports regarding compliance matters directly to the Board of Directors of Envision, and shall be authorized to report on such matters to the Board of Directors at any time. Written documentation of the Compliance Officer’s reports to the Board of Directors shall be made available to OIG upon request; and

		
	c.
	monitoring the day-to-day compliance activities engaged in by Envision as well as for any reporting obligations created under this CIA.

Any noncompliance job responsibilities of the Compliance Officer shall be limited and must not interfere with the Compliance Officer’s ability to perform the duties outlined in this CIA.
Envision shall report to OIG, in writing, any changes in the identity or position description of the Compliance Officer, or any actions or changes that would affect the Compliance Officer’s ability to perform the duties necessary to meet the obligations in this CIA, within five days after such a change.
2.    Compliance Committee. Within 90 days after the Effective Date, Envision shall appoint a Compliance Committee. The Compliance Committee shall, at a minimum, include the Compliance Officer and other members of senior management necessary to meet the requirements of this CIA (e.g., senior executives of relevant departments, such as billing, clinical, human resources, audit, and operations). The Compliance Officer shall chair the Compliance Committee and the Committee shall support the Compliance Officer in fulfilling his/her responsibilities (e.g., shall assist in the analysis of Envision’s risk areas and shall oversee monitoring of internal and external audits and investigations). The Compliance Committee shall meet at least quarterly. The minutes of the Compliance Committee meetings shall be made available to OIG upon request.
Envision shall report to OIG, in writing, any changes in the composition of the Compliance Committee, or any actions or changes that would affect the Compliance Committee’s ability to perform the duties necessary to meet the obligations in this CIA, within 15 days after such a change.

Envision Corporate Integrity Agreement 4

3.    Board of Directors Compliance Obligations. The Board of Directors (or a committee of the Board) of Envision’s parent company – Envision Healthcare Inc. (Board) - shall be responsible for the review and oversight of matters related to compliance with Federal health care program requirements and the obligations of this CIA. The Board must include independent (i.e., non-executive) members.
The Board shall, at a minimum, be responsible for the following:
		
	a.
	meeting at least quarterly to review and oversee Envision’s compliance program, including but not limited to the performance of the Compliance Officer and Compliance Committee;

		
	b.
	submitting to the OIG a description of the documents and other materials it reviewed, as well as any additional steps taken, such as the engagement of an independent advisor or other third party resources, in its oversight of the compliance program and in support of making the resolution below during each Reporting Period;

		
	c.
	for each Reporting Period of the CIA, adopting a resolution, signed by each member of the Board summarizing its review and oversight of Envision’s compliance with Federal health care program requirements and the obligations of this CIA; and

		
	d.
	for the first, third and fourth Reporting Period of the CIA, the Board shall retain an individual or entity with expertise in compliance with Federal health care program requirements (Compliance Expert) to perform a review of the effectiveness of Envision’s Compliance Program (Compliance Program Review). The Compliance Expert shall create a work plan for the Compliance Program Review and prepare a written report about the Compliance Program Review. The written report (Compliance Program Review Report) shall include a description of the Compliance Program Review and any recommendations with respect to Envision’s compliance program. The Board shall review the Compliance Program Review Report as part of its review and oversight of

Envision Corporate Integrity Agreement 5

Envision’s compliance program. A copy of the Compliance Program Review report shall be provided to OIG in each Annual Report submitted by Envision. In addition, copies of any materials provided to the Board by the Compliance Expert, along with minutes of any meetings between the Compliance Expert and the Board, shall be made available to the OIG upon request.
At minimum, the resolution shall include the following language:
“The Board of Directors has made a reasonable inquiry into the operations of Envision’s Compliance Program including the performance of the Compliance Officer and the Compliance Committee. Based on its inquiry and review, the Board has concluded that, to the best of its knowledge, Envision has implemented an effective Compliance Program to meet Federal health care program requirements and the obligations of the CIA.”
If the Board is unable to provide such a conclusion in the resolution, the Board shall include in the resolution a written explanation of the reasons why it is unable to provide the conclusion and the steps it is taking to implement an effective Compliance Program at Envision.
Envision shall report to OIG, in writing, any changes in the composition of the Board, or any actions or changes that would affect the Board’s ability to perform the duties necessary to meet the obligations in this CIA, within 15 days after such a change.

4.    Management Certifications. In addition to the responsibilities set forth in this CIA for all Covered Persons, certain Envision employees (Certifying Employees) are specifically expected to monitor and oversee activities within their areas of authority and shall annually certify that the applicable Envision department is in compliance with applicable Federal health care program requirements and with the obligations of this CIA. These Certifying Employees shall include, at a minimum, all members of senior management and the leaders of all divisions, business units or departments with operations that relate to the Federal health care programs (e.g.,  (i) Chief Executive Officer, Chief Financial Officer, Chief Operating Office, Chief Accounting Officer and Chief Strategy Officer for Envision Healthcare Corporation; (ii) Chief Executive Officer, Chief Financial Officer, Chief Operating Office for Envision Physician Services; and (iii) President, Executive Vice Presidents, Senior Vice Presidents, Regional Medical Directors, and Site 

Envision Corporate Integrity Agreement 6

Medical Directors for Envision Physician Services’ Emergency Medicine, Hospitalist, and Critical Care Service Line.  

For each Reporting Period, each Certifying Employee shall sign a certification that states:

“I have been trained on and understand the compliance requirements and responsibilities as they relate to [insert name of department], an area under my supervision. My job responsibilities include ensuring compliance with regard to the [insert name of department] with all applicable Federal health care program requirements, obligations of the Corporate Integrity Agreement, and Envision policies, and I have taken steps to promote such compliance. To the best of my knowledge, the [insert name of department] of Envision is in compliance with all applicable Federal health care program requirements and the obligations of the Corporate Integrity Agreement. I understand that this certification is being provided to and relied upon by the United States.”

If any Certifying Employee is unable to provide such a certification, the Certifying Employee shall provide a written explanation of the reasons why he or she is unable to provide the certification outlined above.
B.    Written Standards
1.    Code of Conduct. Within 90 days after the Effective Date, Envision shall develop, implement, and distribute a written Code of Conduct to all Covered Persons. Envision shall make the performance of job responsibilities in a manner consistent with the Code of Conduct an element in evaluating the performance of all employees. The Code of Conduct shall, at a minimum, set forth:
		
	a.
	Envision’s commitment to full compliance with all Federal health care program requirements;

		
	b.
	Envision’s requirement that all of its Covered Persons shall be expected to comply with all Federal health care program requirements and with Envision’s own policies and procedures;

		
	c.
	the requirement that all of Envision’s Covered Persons shall be expected to report to the Compliance Officer, or other appropriate individual designated by Envision, suspected violations of any Federal health care program requirements or of Envision’s own Policies and Procedures; and

Envision Corporate Integrity Agreement 7

		
	d.
	the right of all individuals to use the Disclosure Program described in Section III.F, and Envision’s commitment to nonretaliation and to maintain, as appropriate, confidentiality and anonymity with respect to such disclosures.

Within 90 days after the Effective Date, Envision shall distribute the Code of Conduct to all Covered Persons. Envision shall review the Code of Conduct at least annually to determine if revisions are appropriate and shall make any necessary revisions based on such review. The Code of Conduct shall be distributed at least annually to all Covered Persons.
2.    Policies and Procedures. Within 90 days after the Effective Date, Envision shall develop and implement written policies and procedures regarding the operation of its compliance program, including the compliance program requirements outlined in this CIA and Envision’s compliance with Federal health care program requirements (Policies and Procedures). The Policies and Procedures also shall address:
		
	a.
	42 U.S.C. § 1320a-7b(b) (Anti-Kickback Statute) and and the regulations and other guidance documents related to this statute, and business or financial arrangements or contracts that generate unlawful Federal health care program business in violation of the Anti-Kickback Statute; and

		
	b.
	the requirements set forth in Section III.D (Compliance with the Anti-Kickback Statute).

Within 90 days after the Effective Date, the Policies and Procedures shall be distributed to all Covered Persons. Appropriate and knowledgeable staff shall be available to explain the Policies and Procedures. Throughout the term of this CIA, Envision shall enforce and comply with its Policies and Procedures and shall make such compliance an element of evaluating the performance of all employees.
At least annually (and more frequently, if appropriate), Envision shall assess and update, as necessary, the Policies and Procedures. Within 30 days after the effective date of any revisions or addition of new Policies and Procedures, a description of the revisions shall be communicated to all affected Covered Persons and any revised or new Policies and Procedures shall be made available to all Covered Persons.
C.    Training and Education

Envision Corporate Integrity Agreement 8

1.Training Plan. Within 90 days after the Effective Date, Envision shall develop a written plan (Training Plan) that outlines the steps Envision will take to ensure that: (a) all Covered Persons receive adequate training regarding Envision’s CIA requirements and Compliance Program, including the Code of Conduct and an overview of the Anti-Kickback Statute and how this statute could apply to Envision’s business (General Training) and (b) all Arrangements Covered Persons receive adequate training regarding: (i) Arrangements that potentially implicate the Anti-Kickback Statute, as well as the regulations and other guidance documents related to this statute; (ii) Envision’s policies, procedures, and other requirements relating to Arrangements and Focus Arrangements, including but not limited to the Focus Arrangements Tracking System, the internal review and approval process, and the tracking of remuneration to and from sources of health care business or referrals required by Section III.D of the CIA; (iii) the personal obligation of each individual involved in the development, approval, management, or review of Envision’s Arrangements to know the applicable legal requirements and the Envision’s policies and procedures; (iv) the legal sanctions under the Anti-Kickback Statute; and (v) examples of violations of the Anti-Kickback Statute.
The Training Plan shall include information regarding the training topics, the identification of Covered Persons and Arrangements Covered Persons required to attend each training session, the length of the training, the schedule for training, and the format of the training. Within 30 days of the OIG’s receipt of Envision’s Training Plan, OIG will notify Envision of any comments or objections to the Training Plan. Absent notification by the OIG that the Training Plan is unacceptable, Envision may implement its Training Plan. Envision shall furnish training to its Covered Persons and Arrangements Covered Persons pursuant to the Training Plan during each Reporting Period.
2.Board Member Training. Within 90 days after the Effective Date, Envision shall provide at least two hours of training to each member of the Board of Directors. This training shall address Envision’s CIA requirements and Compliance Program (including the Code of Conduct), the corporate governance responsibilities of board members, and the responsibilities of board members with respect to review and oversight of the Compliance Program. Specifically, the training shall address the unique responsibilities of health care Board members, including the risks, oversight areas, and strategic approaches to conducting oversight of a health care entity. This training may be conducted by an outside compliance expert hired by the Board and should include a discussion of the OIG’s guidance on Board member responsibilities.

Envision Corporate Integrity Agreement 9

New members of the Board of Directors shall receive the Board Member Training described above within 30 days after becoming a member or within 90 days after the Effective Date, whichever is later.
3.Certification. Each individual who is required to attend training shall certify, in writing or in electronic form, that he or she has received the required training. The certification shall specify the type of training received and the date received. The Compliance Officer (or designee) shall retain the certifications, along with all course materials.
4.Qualifications of Trainer. Persons providing the training shall be knowledgeable about the subject area.
5.Update of Training Plan. Envision shall review the Training Plan annually, and, where appropriate, update the Training Plan to reflect changes in Federal health care program requirements, any issues discovered during internal audits or the Arrangements Review, and any other relevant information. Any updates to the Training Plan must be reviewed and approved by the OIG prior to the implementation of the revised Training Plan. Within 30 days of OIG’s receipt of any updates or revisions to Envision’s Training Plan, OIG will notify Envision of any comments or objections to the revised Training Plan. Absent notification from the OIG that the revised Training Plan is unacceptable, Envision may implement the revised Training Plan.
6.Computer-based Training. Envision may provide the training required under this CIA through appropriate computer-based training approaches. If Envision chooses to provide computer-based training, it shall make available appropriately qualified and knowledgeable staff or trainers to answer questions or provide additional information to the individuals receiving such training.
D.    Compliance with the Anti-Kickback Statute
1.    Focus Arrangements Procedures. Within 90 days after the Effective Date, Envision shall create procedures reasonably designed to ensure that each existing and new or renewed Focus Arrangement does not violate the Anti-Kickback Statute or the regulations, directives, and guidance related to this statute (Focus Arrangements Procedures). These procedures shall include the following:

Envision Corporate Integrity Agreement 10

		
	a.
	creating and maintaining a centralized tracking system for all existing and new or renewed Focus Arrangements (Focus Arrangements Tracking System);

		
	b.
	tracking remuneration to and from all parties to Focus Arrangements (if applicable); 

		
	c.
	tracking service and activity logs to ensure that parties to the Focus Arrangement are performing the services required under the applicable Focus Arrangement(s) (if applicable);

		
	d.
	monitoring the use of leased space, medical supplies, medical devices, equipment, or other patient care items to ensure that such use is consistent with the terms of the applicable Focus Arrangement(s) (if applicable);

		
	e.
	establishing and implementing a written review and approval process for all Focus Arrangements, the purpose of which is to ensure that all new and existing or renewed Focus Arrangements do not violate the Anti-Kickback Statute and that includes at least the following: (i) a legal review of all Focus Arrangements by counsel with expertise in the Anti-Kickback Statute, (ii) a process for specifying the business need or business rationale for all Focus Arrangements, and (iii) a process for determining and documenting the fair market value of the remuneration specified in the Focus Arrangement (if applicable);

		
	f.
	requiring the Compliance Officer to review the Focus Arrangements Tracking System, internal review and approval process, and other Focus Arrangements Procedures on at least an annual basis and to provide a report on the results of such review to the Compliance Committee; and

		
	g.
	implementing effective responses when suspected violations of the Anti-Kickback Statute are discovered, including disclosing Reportable Events and quantifying and repaying Overpayments pursuant to Sections III.I and III.J when appropriate.

Envision Corporate Integrity Agreement 11

2.    New or Renewed Focus Arrangements. Prior to entering into new Focus Arrangements or renewing existing Focus Arrangements, in addition to complying with the Focus Arrangements Procedures set forth above, Envision shall comply with the following requirements (Focus Arrangements Requirements):
		
	a.
	Ensure that each Focus Arrangement is set forth in writing and signed by Envision and the other parties to the Focus Arrangement;

		
	b.
	Include in the written agreement a requirement that each party to a Focus Arrangement who meets the definition of a Covered Person shall complete at least one hour of training regarding the Anti-Kickback Statute and examples of arrangements that potentially implicate the Anti-Kickback Statute. Additionally, Envision shall provide each party to the Focus Arrangement with a copy of its Code of Conduct and Anti-Kickback Statute Policies and Procedures; and

		
	c.
	Include in the written agreement a certification by the parties to the Focus Arrangement that the parties shall not violate the Anti-Kickback Statute with respect to the performance of the Arrangement.

3.    Focus Arrangements Tracking System Verification and Certification. For each Reporting Period, the Compliance Officer shall review the entries in Envision’s Focus Arrangements Tracking System and certify in writing to OIG that, to the best of his or her knowledge, the Focus Arrangements Tracking System is complete and accurate, except for any discrepancies identified. The Compliance Officer shall provide an explanation for: (1) any Focus Arrangements found to have been missing from the Focus Arrangements Tracking System; and (2) any entries in the Focus Arrangements Tracking System found to have been incomplete or inaccurate.
4.    Records Retention and Access. Envision shall retain and make available to OIG, upon request, the Focus Arrangements Tracking System and all supporting documentation of the Focus Arrangements subject to this Section and, to the extent available, all non-privileged communications related to the Focus Arrangements and the actual performance of the duties under the Focus Arrangements.

Envision Corporate Integrity Agreement 12

E.    Review Procedures
1.    General Description.
		
	a.
	Engagement of Legal Independent Review Organization. Within 90 days after the Effective Date, Envision shall engage a legal entity (or entities), (hereinafter “Legal Independent Review Organization” or “Legal IRO”), to perform the reviews listed in this Section III.E. The applicable requirements relating to the Legal IRO are outlined in Appendix A to this CIA, which is incorporated by reference.

		
	b.
	Retention of Records. The Legal IRO and Envision shall retain and make available to OIG, upon request, all work papers, supporting documentation, correspondence, and draft reports (those exchanged between the Legal IRO and Envision) related to the reviews.

		
	c.
	Responsibilities and Liabilities. Nothing in this Section III.E affects Envision’s responsibilities or liabilities under any criminal, civil, or administrative laws or regulations applicable to any Federal health care program including, but not limited to, the Anti-Kickback Statute.

2.    Focus Arrangements Review. The Legal IRO shall perform a Focus Arrangements Review and prepare a Focus Arrangements Review Report as outlined in Appendix B to this CIA, which is incorporated by reference.
3.    Validation Review. In the event OIG has reason to believe that: (a) any Focus Arrangements Review fails to conform to the requirements of this CIA; or (b) the Legal IRO’s findings or Focus Arrangements Review results are inaccurate, OIG may, at its sole discretion, conduct its own review to determine whether the Focus Arrangements Review complied with the requirements of the CIA and/or the findings or Focus Arrangements Review results are inaccurate (Validation Review). Envision shall pay for the reasonable cost of any such review performed by OIG or any of its designated agents. Any Validation Review of a Focus Arrangements Review submitted as part of Envision’s final Annual Report shall be initiated no later than one year after Envision’s final submission (as described in Section II) is received by OIG.

Envision Corporate Integrity Agreement 13

Prior to initiating a Validation Review, OIG shall notify Envision in writing of its intent to do so and provide an explanation of the reasons OIG has determined a Validation Review is necessary. Envision shall have 30 days following the date of the OIG’s written notice to submit a written response to OIG that includes any additional or relevant information to clarify the results of the Focus Arrangements Review or to correct the inaccuracy of the Focus Arrangements Review and/or propose alternatives to the proposed Validation Review. The final determination as to whether or not to proceed with a Validation Review shall be made at the sole discretion of OIG.
4.    Certification Regarding Legal IRO’s Relationship to Envision. The Legal IRO shall include in its report(s) to Envision a certification that the Legal IRO: (1) has not previously represented or been employed or engaged by Envision; and (2) does not have a relationship to Envision or its employees, officers, or directors that would cause a reasonable person to question the Legal IRO’s impartiality.
F.Risk Assessment and Internal Review Process
Within 90 days after the Effective Date, Envision shall develop and implement a centralized annual risk assessment and internal review process to identify and address risks associated with Arrangements (as defined in Section II.C.1 above). The risk assessment and internal review process should require compliance, legal and department leaders, at least annually, to: (1) identify and prioritize risks, (2) develop internal audit work plans related to the identified risk areas, (3) implement the internal audit work plans, (4) develop corrective action plans in response to the results of any internal audits performed, and (5) track the implementation of the corrective action plans in order to assess the effectiveness of such plans. Envision shall maintain the risk assessment and internal review process for the term of the CIA.
G.Disclosure Program
Within 90 days after the Effective Date, Envision shall establish a Disclosure Program that includes a mechanism (e.g., a toll-free compliance telephone line) to enable individuals to disclose, to the Compliance Officer or some other person who is not in the disclosing individual’s chain of command, any identified issues or questions associated with Envision’s policies, conduct, practices, or procedures with respect to a Federal health care program believed by the individual to be a potential violation of criminal, civil, or administrative law. Envision shall appropriately publicize the existence of the

Envision Corporate Integrity Agreement 14

disclosure mechanism (e.g., via periodic e-mails to employees or by posting the information in prominent common areas).
The Disclosure Program shall emphasize a nonretribution, nonretaliation policy, and shall include a reporting mechanism for anonymous communications for which appropriate confidentiality shall be maintained. Upon receipt of a disclosure, the Compliance Officer (or designee) shall gather all relevant information from the
disclosing individual. The Compliance Officer (or designee) shall make a preliminary, good faith inquiry into the allegations set forth in every disclosure to ensure that he or she has obtained all of the information necessary to determine whether a further review should be conducted. For any disclosure that is sufficiently specific so that it reasonably:
(1)permits a determination of the appropriateness of the alleged improper practice; and
(2)provides an opportunity for taking corrective action, Envision shall conduct an internal review of the allegations set forth in the disclosure and ensure that proper follow-up is conducted.
The Compliance Officer (or designee) shall maintain a disclosure log and shall record each disclosure in the disclosure log within two business days of receipt of the disclosure. The disclosure log shall include a summary of each disclosure received (whether anonymous or not), the status of the respective internal reviews, and any corrective action taken in response to the internal reviews.
H.    Ineligible Persons
1.    Definitions. For purposes of this CIA:
		
	a.
	an “Ineligible Person” shall include an individual or entity who:

		
	i.
	is currently excluded, debarred, suspended, or otherwise ineligible to participate in the Federal health care programs or in Federal procurement or nonprocurement programs; or

		
	ii.
	has been convicted of a criminal offense that falls within the scope of 42 U.S.C. § 1320a-7(a), but has not yet been excluded, debarred, suspended, or otherwise declared ineligible.

Envision Corporate Integrity Agreement 15

b.    “Exclusion Lists” include:
		
	i.
	the HHS/OIG List of Excluded Individuals/Entities

(LEIE) (available through the Internet
at http://www.oig.hhs.gov); and
		
	ii.
	the General Services Administration’s System for Award Management (SAM) (available through the Internet at http://www.sam.gov). 

2.    Screening Requirements. Envision shall ensure that all prospective and current Covered Persons are not Ineligible Persons, by implementing the following screening requirements.
		
	a.
	Envision shall screen all prospective Covered Persons against the Exclusion Lists prior to engaging their services and, as part of the hiring or contracting process, shall require such Covered Persons to disclose whether they are Ineligible Persons.

		
	b.
	Envision shall screen all current Covered Persons against the Exclusion Lists within 90 days after the Effective Date and thereafter shall screen against the LEIE on a monthly basis and screen against SAM on an annual basis.

		
	c.
	Envision shall implement a policy requiring all Covered Persons to disclose immediately any debarment, exclusion, suspension, or other event that makes that person an Ineligible Person.

Nothing in this Section III.H affects Envision’s responsibility to refrain from (and liability for) billing Federal health care programs for items or services furnished, ordered, or prescribed by an excluded person. Envision understands that items or services furnished, ordered, or prescribed by excluded persons are not payable by Federal health care programs and that Envision may be liable for overpayments and/or criminal, civil, and administrative sanctions for employing or contracting with an excluded person regardless of whether Envision meets the requirements of Section III.H.

Envision Corporate Integrity Agreement 16

3.Removal Requirement. If Envision has actual notice that a Covered Person has become an Ineligible Person, Envision shall remove such Covered Person from responsibility for, or involvement with, Envision’s business operations related to the Federal health care programs and shall remove such Covered Person from any position for which the Covered Person’s compensation or the items or services furnished, ordered, or prescribed by the Covered Person are paid in whole or part, directly or indirectly, by Federal health care programs or otherwise with Federal funds at least until such time as the Covered Person is reinstated into participation in the Federal health care programs.
4.Pending Charges and Proposed Exclusions. If Envision has actual notice that a Covered Person is charged with a criminal offense that falls within the scope of 42 U.S.C. §§ 1320a-7(a), 1320a-7(b)(1)-(3), or is proposed for exclusion during the Covered Person’s employment or contract term or, Envision shall take all appropriate actions to ensure that the responsibilities of that Covered Person have not and shall not adversely affect the quality of care rendered to any beneficiary or the accuracy of any claims submitted to any Federal health care program.
I.Notification of Government Investigation or Legal Proceeding
Within 30 days after discovery, Envision shall notify OIG, in writing, of any ongoing investigation or legal proceeding known to Envision conducted or brought by a governmental entity or its agents involving an allegation that Envision has committed a crime or has engaged in fraudulent activities. This notification shall include a description of the allegation, the identity of the investigating or prosecuting agency, and the status of such investigation or legal proceeding. Envision shall also provide written notice to OIG within 30 days after the resolution of the matter, and shall provide OIG with a description of the findings and/or results of the investigation or proceeding, if any.
J.Overpayments 
1.Definition of Overpayments. For purposes of this CIA, an “Overpayment” shall mean the amount of money Envision has received in excess of the amount due and payable under any Federal health care program requirements.
2.Overpayment Policies and Procedures. Within 90 days after the Effective Date, Envision shall develop and implement written policies and procedures regarding the identification, quantification and repayment of Overpayments received from any Federal health care program.

Envision Corporate Integrity Agreement 17

3.    Repayment of Overpayments.
		
	a.
	If, at any time, Envision identifies any Overpayment, Envision shall repay the Overpayment to the appropriate payor (e.g., Medicare contractor) within 60 days after identification of the Overpayment and take remedial steps within 90 days after identification (or such additional time as may be agreed to by the payor) to correct the problem, including preventing the underlying problem and the Overpayment from recurring. If not yet quantified, within 60 days after identification, Envision shall notify the payor of its efforts to quantify the Overpayment amount along with a schedule of when such work is expected to be completed. Notification and repayment to the payor shall be done in accordance with the payor’s policies.

		
	b.
	Notwithstanding the above, notification and repayment of any Overpayment amount that routinely is reconciled or adjusted pursuant to policies and procedures established by the payor should be handled in accordance with such policies and procedures.

K.    Reportable Events
1.    Definition of Reportable Event. For purposes of this CIA, a “Reportable Event” means anything that involves:
		
	a.
	a substantial Overpayment;

		
	b.
	a matter that a reasonable person would consider a probable violation of criminal, civil, or administrative laws applicable to any Federal health care program for which penalties or exclusion may be authorized;

		
	c.
	the employment of or contracting with a Covered Person who is an Ineligible Person as defined by Section III.H.1.a; or

		
	d.
	the filing of a bankruptcy petition by Envision.

Envision Corporate Integrity Agreement 18

A Reportable Event may be the result of an isolated event or a series of occurrences.
2.    Reporting of Reportable Events. If Envision determines (after a reasonable opportunity to conduct an appropriate review or investigation of the allegations) through any means that there is a Reportable Event, Envision shall notify OIG, in writing, within 30 days after making the determination that the Reportable Event exists.
3.    Reportable Events under Section III.K.1.a. For Reportable Events under Section III.K.1.a, the report to OIG shall be made within 30 days after making the determination that a substantial Overpayment exists and shall include:
		
	a.
	a complete description of all details relevant to the Reportable Event, including, at a minimum, the types of claims, transactions, or other conduct giving rise to the Reportable Event; the period during which the conduct occurred; and the names of entities and individuals believed to be implicated, including an explanation of their roles in the Reportable Event;

		
	b.
	the Federal health care programs affected by the Reportable Event;

		
	c.
	a description of the steps taken by Envision to identify and quantify the Overpayment; and

		
	d.
	a description of Envision’s actions taken to correct the Reportable Event and prevent it from recurring.

Within 60 days of identification of the Overpayment, Envision shall provide OIG with a copy of the notification and repayment (if quantified) to the payor required in Section III.J.3.
4.    Reportable Events under Section III.K.1.b. For Reportable Events under Section III.K.1.b, the report to OIG shall include:
		
	a.
	a complete description of all details relevant to the Reportable Event, including, at a minimum, the types of claims, transactions or other conduct giving rise to the Reportable

Envision Corporate Integrity Agreement 19

Event; the period during which the conduct occurred; and the names of entities and individuals believed to be implicated, including an explanation of their roles in the Reportable Event;
		
	b.
	a statement of the Federal criminal, civil or administrative laws that are probably violated by the Reportable Event;

		
	c.
	the Federal health care programs affected by the Reportable Event;

		
	d.
	a description of Envision’s actions taken to correct the Reportable Event and prevent it from recurring; and

		
	e.
	if the Reportable Event has resulted in an Overpayment, a description of the steps taken by Envision to identify and quantify the Overpayment.

5.    Reportable Events under Section III.K.1.c. For Reportable Events under Section III.K.1.c, the report to OIG shall include:
		
	a.
	the identity of the Ineligible Person and the job duties performed by that individual;

		
	b.
	the dates of the Ineligible Person’s employment or contractual relationship;

		
	c.
	a description of the Exclusion Lists screening that Envision completed before and/or during the Ineligible Person’s employment or contract and any flaw or breakdown in the Ineligible Persons screening process that led to the hiring or contracting with the Ineligible Person;

		
	d.
	a description of how the Reportable Event was discovered; and

		
	e.
	a description of any corrective action implemented to prevent future employment or contracting with an Ineligible Person.

Envision Corporate Integrity Agreement 20

6.    Reportable Events under Section III.K.1.d. For Reportable Events under Section III.K.1.d, the report to the OIG shall include documentation of the bankruptcy filing and a description of any Federal health care program authorities implicated.
		
	IV.
	SUCCESSOR LIABILITY; CHANGES TO BUSINESS UNITS OR LOCATIONS 

A.Sale of Business, Business Unit or Location.
In the event that, after the Effective Date, Envision proposes to sell any or all of its business, business units or locations (whether through a sale of assets, sale of stock, or other type of transaction) that are subject to this CIA, Envision shall notify OIG of the proposed sale at least 30 days prior to the sale of its business, business unit or location. This notification shall include a description of the business, business unit or location to be sold, a brief description of the terms of the sale, and the name and contact information of the prospective purchaser. This CIA shall be binding on the purchaser of the business, business unit or location, unless otherwise determined and agreed to in writing by the OIG.
B.Change or Closure of Business, Business Unit or Location
After the Effective Date, on a quarterly basis, Envision will notify OIG of any change in locations or closures of any business, business unit or location that is subject to this CIA.
C.Purchase or Establishment of New Business, Business Unit or Location
After the Effective Date, on a quarterly basis, Envision shall notify OIG of any new business relating to the furnishing of items or services that may be reimbursed by Federal health care programs. This notification shall include the address of the new business, business unit or location, phone number, fax number, the location’s Medicare and state Medicaid program provider number and/or supplier number(s) and the name and address of each Medicare and state Medicaid program contractor to which Envision currently submits claims. Each new business, business unit or location and all Covered Persons at each new business, business unit or location shall be subject to the applicable requirements of this CIA, unless otherwise agreed to determined and in writing by the OIG.
V.    IMPLEMENTATION AND ANNUAL REPORTS 

Envision Corporate Integrity Agreement 21

A.    Implementation Report
Within 120 days after the Effective Date, Envision shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include:
1.the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;
2.the names and positions of the members of the Compliance Committee required by Section III.A;
3.the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3;
4.the names and positions of the Certifying Employees required by Section III.A.4;
5.a copy of Envision’s Code of Conduct required by Section III.B.1;
6.a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request);
7.the certification regarding the completeness and accuracy of the Focus Arrangements Tracking System required by Section III.D.3, as well as an explanation of: (1) any Focus Arrangements found to have been missing from the Focus Arrangements Tracking System; and (2) any entries in the Focus Arrangements Tracking System found to have been incomplete or inaccurate;
7.    the Training Plan required by Section III.C.1 and a description of the Board of Directors training required by Section III.C.2 (including a summary of the topics covered, the length of the training, and when the training was provided);
8.a description of (a) the Focus Arrangements Tracking System required by Section III.D.1.a, (b) the internal review and approval process required by Section III.D.1.e; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1;

Envision Corporate Integrity Agreement 22

9.the following information regarding the Legal IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the Legal IRO has the qualifications outlined in Appendix A to this CIA; (d) a summary and description of any and all current and prior engagements and agreements between Envision and the Legal IRO; and (e) a certification from the Legal IRO that it does not have a prohibited relationship to Envision as set forth in Section III.E.4;
10.a description of the risk assessment and internal review process required by Section III.F;
11.a description of the Disclosure Program required by Section III.G;
12.a certification that Envision has implemented the screening requirements described in Section III.H regarding Ineligible Persons, or a description of why Envision cannot provide such a certification;
13.a copy of Envision’s policies and procedures regarding the identification, quantification and repayment of Overpayments required by Section III.J;
14.a list of all of Envision’s locations (including locations and mailing addresses), the corresponding name under which each location is doing business, the corresponding phone numbers and fax numbers, each location’s Medicare and state Medicaid program provider number(s) and/or supplier number(s), and the name and address of each Medicare and state Medicaid program contractor to which Envision currently submits claims;
15.a description of Envision’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business;
16.any individual owners; and
17.the certifications required by Section V.C.
B.    Annual Reports 

Envision Corporate Integrity Agreement 23

Envision shall submit to OIG annually a report with respect to the status of, and findings regarding, Envision’s compliance activities for each of the five Reporting Periods (Annual Report). Each Annual Report shall include, at a minimum:
1.any change in the identity, position description, or other noncompliance job responsibilities of the Compliance Officer; any change in the membership of the Compliance Committee described in Section III.A, any change in the Board members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.3, and any change in the group of Certifying Employees described in Section III.A.4;
2.the dates of each report made by the Compliance Officer to the Board (written documentation of such reports shall be made available to OIG upon request);
3.the Board resolution required by Section III.A.3 and a description of the documents and other materials reviewed by the Board, as well as any additional steps taken, in its oversight of the compliance program and in support of making the resolution;
4.a summary of any changes or amendments to Envision’s Code of Conduct or the Policies and Procedures required by Section III.B and the reasons for such changes (e.g., change in contractor policy);
5.a copy of Envision’s Training Plan developed under Section III.C and the following information regarding each type of training required by the Training Plan: a description of the training, including a summary of the topics covered; the length of sessions, a schedule of training sessions, a general description of the categories of individuals required to complete the training, and the process by which Envision ensures that all designated employees receive appropriate training. A copy of all training materials and the documentation to support this information shall be made available to OIG upon request.
6.a description of (a) any changes to the Focus Arrangements Tracking System required by Section III.D.1.a; (b) any changes to the internal review and approval process required by Section III.D.1.e; and (c) any changes to the tracking and monitoring procedures and other Arrangements Procedures required by Section III.D.1;
7.the certification regarding the completeness and accuracy of the Focus Arrangements Tracking System required by Section III.D.3 as well as an

Envision Corporate Integrity Agreement 24

explanation of: (1) any Focus Arrangements found to have been missing from the Focus Arrangements Tracking System; and (2) any entries in the Focus Arrangements Tracking System found to have been incomplete or inaccurate;
8.a complete copy of all reports prepared pursuant to Section III.E, along with a copy of the Legal IRO’s engagement letter and Envision’s response to the reports, along with corrective action plan(s) related to any issues raised by the reports;
9.a certification from the Legal IRO that it does not have a prohibited relationship to Envision as set forth in Section III.E.4;
10.a description of the risk assessment and internal review process required by Section III.F., a summary of any changes to the process and a description of the reasons for such changes;
11.a summary of all internal audits performed pursuant to Section III.F during the Reporting Period and any corrective action plans developed in response to those internal audits. Copies of the internal audit reports and corrective actions plans shall be made available to OIG upon request;
12.a summary of the disclosures in the disclosure log required by Section III.G that: (a) relate to Federal health care programs; or (b) involve allegations of conduct that may involve illegal remuneration or inappropriate referrals in violation of the Anti-Kickback Statute (the complete disclosure log shall be made available to OIG upon request);
13.a certification that Envision has completed the screening required by Section III.H regarding Ineligible Persons;
14.a summary describing any ongoing investigation or legal proceeding required to have been reported pursuant to Section III.I. The summary shall include a description of the allegation, the identity of the investigating or prosecuting agency, and the status of such investigation or legal proceeding;
15.a description of any changes to the Overpayment policies and procedures required by Section III.K, including the reasons for such changes;
16.a report of the aggregate Overpayments that have been returned to the Federal health care programs. Overpayment amounts shall be broken down into the

Envision Corporate Integrity Agreement 25

following categories: inpatient Medicare, outpatient Medicare, Medicaid (report each applicable state separately, if applicable), and other Federal health care programs. Overpayment amounts that are routinely reconciled or adjusted pursuant to policies and procedures established by the payor do not need to be included in this aggregate Overpayment report;
17.a summary of Reportable Events (as defined in Section III.K) identified during the Reporting Period and the status of any corrective action relating to all such Reportable Events;
18.a description of all changes to the most recently provided list of Envision’s locations (including addresses) as required by Section V.A.14;
19.the certifications required by Section V.C.; and
20.a copy of the Compliance Program Review Report.
The first Annual Report shall be received by OIG no later than 60 days after the end of the first Reporting Period. Subsequent Annual Reports shall be received by OIG no later than the anniversary date of the due date of the first Annual Report.
C.    Certifications 
1.Certifying Employees. In each Annual Report, Envision shall include the certifications of Certifying Employees as required by Section III.A.4;
2.Compliance Officer and Chief Executive Officer. The Implementation Report and each Annual Report shall include a certification by the Compliance Officer and Chief Executive Officer that:
		
	a.
	to the best of his or her knowledge, except as otherwise described in the report, Envision is in compliance with all of the requirements of this CIA;

		
	b.
	to the best of his or her knowledge, Envision has implemented procedures reasonably designed to ensure that all Focus Arrangements do not violate the Anti-Kickback Statute, including the Focus Arrangements Procedures required in Section III.D of the CIA;

Envision Corporate Integrity Agreement 26

		
	c.
	to the best of his or her knowledge, Envision has fulfilled the requirements for New and Renewed Focus Arrangements under Section III.D.2 of the CIA; and

		
	d.
	he or she has reviewed the report and has made reasonable inquiry regarding its content and believes that the information in the report is accurate and truthful.

3.    Chief Financial Officer. The first Annual Report shall include a certification by the Chief Financial Officer that, to the best of his or her knowledge, Envision has complied with its obligations under the Settlement Agreement: (a) not to resubmit to any Federal health care program payors any previously denied claims related to the Covered Conduct addressed in the Settlement Agreement, and not to appeal any such denials of claims; (b) not to charge to or otherwise seek payment from federal or state payors for unallowable costs (as defined in the Settlement Agreement); and (c) to identify and adjust any past charges or claims for unallowable costs.
D.    Designation of Information
Envision shall clearly identify any portions of its submissions that it believes are trade secrets, or information that is commercial or financial and privileged or confidential, and therefore potentially exempt from disclosure under the Freedom of Information Act (FOIA), 5 U.S.C. § 552. Envision shall refrain from identifying any information as exempt from disclosure if that information does not meet the criteria for exemption from disclosure under FOIA.
VI.    NOTIFICATIONS AND SUBMISSION OF REPORTS
Unless otherwise stated in writing after the Effective Date, all notifications and reports required under this CIA shall be submitted to the following entities:
OIG: 
Administrative and Civil Remedies Branch Office of Counsel to the Inspector General Office of Inspector General
U.S. Department of Health and Human Services Cohen Building, Room 5527

Envision Corporate Integrity Agreement 27

330 Independence Avenue, S.W.
Washington, DC 20201  
Telephone: 202.619.2078  
Facsimile: 202.205.0604
Envision: 
Ross Ronan
Chief Compliance Officer  
13737 Noel Road, Ste. 1600  
Dallas, TX 75240
Telephone: 303.495.1200  
Facsimile: 303.495.1649
Unless otherwise specified, all notifications and reports required by this CIA may be made by certified mail, overnight mail, hand delivery, or other means, provided that there is proof that such notification was received. For purposes of this requirement, internal facsimile confirmation sheets do not constitute proof of receipt. Upon request by OIG, Envision may be required to provide OIG with an electronic copy of each notification or report required by this CIA in searchable portable document format (pdf), in addition to a paper copy.
VII. OIG INSPECTION, AUDIT, AND REVIEW RIGHTS
In addition to any other rights OIG may have by statute, regulation, or contract, OIG or its duly authorized representative(s) may examine and/or request copies of Envision’s books, records, and other documents and supporting materials and/or conduct on-site reviews of any of Envision’s locations for the purpose of verifying and
evaluating: (a) Envision’s compliance with the terms of this CIA; and (b) Envision’s compliance with the requirements of the Federal health care programs. The documentation described above shall be made available by Envision to OIG or its duly authorized representative(s) at all reasonable times for inspection, audit, and/or reproduction. Furthermore, for purposes of this provision, OIG or its duly authorized representative(s) may interview any of Envision’s Covered Persons who consent to be interviewed at the individual’s place of business during normal business hours or at such other place and time as may be mutually agreed upon between the individual and OIG. Envision shall assist OIG or its duly authorized representative(s) in contacting and arranging interviews with such individuals upon OIG’s request. Envision’s Covered Persons may elect to be interviewed with or without a representative of Envision present.

Envision Corporate Integrity Agreement 28

VIII.DOCUMENT AND RECORD RETENTION
Envision shall maintain for inspection all documents and records relating to reimbursement from the Federal health care programs and to compliance with this CIA for six years (or longer if otherwise required by law) from the Effective Date.
IX.DISCLOSURES 
Consistent with HHS’s FOIA procedures, set forth in 45 C.F.R. Part 5, OIG shall make a reasonable effort to notify Envision prior to any release by OIG of information submitted by Envision pursuant to its obligations under this CIA and identified upon submission by Envision as trade secrets, or information that is commercial or financial and privileged or confidential, under the FOIA rules. With respect to such releases, Envision shall have the rights set forth at 45 C.F.R. § 5.65(d).
X.BREACH AND DEFAULT PROVISIONS 
Envision is expected to fully and timely comply with all of its CIA obligations.
A.    Stipulated Penalties for Failure to Comply with Certain Obligations 
As a contractual remedy, Envision and OIG hereby agree that failure to comply with certain obligations as set forth in this CIA may lead to the imposition of the following monetary penalties (hereinafter referred to as “Stipulated Penalties”) in accordance with the following provisions.
1.    A Stipulated Penalty of $2,500 (which shall begin to accrue on the day after the date the obligation became due) for each day Envision fails to establish and implement any of the following obligations as described in Sections III and IV:
		
	a.
	a Compliance Officer;

		
	b.
	a Compliance Committee;

		
	c.
	the Board of Directors compliance obligations and the performance of a Compliance Program Review, and the preparation of a Compliance Program Review Report, as required by Section III.A.3;

Envision Corporate Integrity Agreement 29

		
	d.
	the management certification obligations;

		
	e.
	a written Code of Conduct;

		
	f.
	written Policies and Procedures;

		
	g.
	the development and/or implementation of a Training Plan for the training of Covered Persons, Arrangements Covered Persons, and Board Members;

		
	h.
	the Focus Arrangements Procedures and/or Focus

Arrangements Requirements described in Sections III.D.1 and III.D.2;
		
	i.
	a risk assessment and internal review process as required by Section III.F;

		
	j.
	a Disclosure Program;

		
	k.
	Ineligible Persons screening and removal requirements;

		
	l.
	notification of Government investigations or legal proceedings;

		
	m.
	policies and procedures regarding the repayment of Overpayments;

		
	n.
	the repayment of Overpayments as required by Section III.J and Appendix B;

		
	o.
	reporting of Reportable Events; and

		
	p.
	disclosure of changes to business units or locations.

2.    A Stipulated Penalty of $2,500 (which shall begin to accrue on the day after the date the obligation became due) for each day Envision fails to engage and use a Legal IRO, as required by Section III.E, Appendix A, or Appendix B.

Envision Corporate Integrity Agreement 30

3.A Stipulated Penalty of $2,500 (which shall begin to accrue on the day after the date the obligation became due) for each day Envision fails to submit the Implementation Report or any Annual Reports to OIG in accordance with the requirements of Section V by the deadlines for submission.
4.A Stipulated Penalty of $2,500 (which shall begin to accrue on the day after the date the obligation became due) for each day Envision fails to submit any Focus Arrangements Review Report in accordance with the requirements of Section III.E and Appendix B.
5.A Stipulated Penalty of $1,500 for each day Envision fails to grant access as required in Section VII. (This Stipulated Penalty shall begin to accrue on the date Envision fails to grant access.)
6.A Stipulated Penalty of $50,000 for each false certification
submitted by or on behalf of Envision as part of its Implementation Report, any Annual Report, additional documentation to a report (as requested by the OIG), or otherwise required by this CIA.
7.A Stipulated Penalty of $1,000 for each day Envision fails to comply fully and adequately with any obligation of this CIA. OIG shall provide notice to Envision stating the specific grounds for its determination that Envision has failed to comply fully and adequately with the CIA obligation(s) at issue and steps Envision shall take to comply with the CIA. (This Stipulated Penalty shall begin to accrue 10 days after the date Envision receives this notice from OIG of the failure to comply.) A Stipulated Penalty as described in this Subsection shall not be demanded for any violation for which OIG has sought a Stipulated Penalty under Subsections 1-6 of this Section.
B.    Timely Written Requests for Extensions
Envision may, in advance of the due date, submit a timely written request for an extension of time to perform any act or file any notification or report required by this CIA. Notwithstanding any other provision in this Section, if OIG grants the timely written request with respect to an act, notification, or report, Stipulated Penalties for failure to perform the act or file the notification or report shall not begin to accrue until one day after Envision fails to meet the revised deadline set by OIG. Notwithstanding any other provision in this Section, if OIG denies such a timely written request, Stipulated Penalties for failure to perform the act or file the notification or report shall not

Envision Corporate Integrity Agreement 31

begin to accrue until three days after Envision receives OIG’s written denial of such request or the original due date, whichever is later. A “timely written request” is defined as a request in writing received by OIG at least five days prior to the date by which any act is due to be performed or any notification or report is due to be filed.
C.    Payment of Stipulated Penalties
1.Demand Letter. Upon a finding that Envision has failed to comply with any of the obligations described in Section X.A and after determining that Stipulated Penalties are appropriate, OIG shall notify Envision of: (a) Envision’s failure to comply; and (b) OIG’s exercise of its contractual right to demand payment of the Stipulated Penalties. (This notification shall be referred to as the “Demand Letter.”)
2.Response to Demand Letter. Within 10 days after the receipt of the Demand Letter, Envision shall either: (a) cure the breach to OIG’s satisfaction and pay the applicable Stipulated Penalties or (b) request a hearing before an HHS administrative law judge (ALJ) to dispute OIG’s determination of noncompliance, pursuant to the agreed upon provisions set forth below in Section X.E. In the event Envision elects to request an ALJ hearing, the Stipulated Penalties shall continue to accrue until Envision cures, to OIG’s satisfaction, the alleged breach in dispute. Failure to respond to the Demand Letter in one of these two manners within the allowed time period shall be considered a material breach of this CIA and shall be grounds for exclusion under Section X.D.
3.Form of Payment. Payment of the Stipulated Penalties shall be made by electronic funds transfer to an account specified by OIG in the Demand Letter.
4.Independence from Material Breach Determination. Except as set forth in Section X.D.1.c, these provisions for payment of Stipulated Penalties shall not affect or otherwise set a standard for OIG’s decision that Envision has materially breached this CIA, which decision shall be made at OIG’s discretion and shall be governed by the provisions in Section X.D, below.
D.    Exclusion for Material Breach of this CIA
1.    Definition of Material Breach. A material breach of this CIA means:

Envision Corporate Integrity Agreement 32

		
	a.
	a failure by Envision to report a Reportable Event, take corrective action, or make the appropriate refunds, as required in Section III.K;

		
	b.
	repeated violations or a flagrant violation of any of the obligations under this CIA, including, but not limited to, the obligations addressed in Section X.A;

		
	c.
	a failure to respond to a Demand Letter concerning the payment of Stipulated Penalties in accordance with Section X.C; or

		
	d.
	a failure to engage and use an Legal IRO in accordance with Section III.E, Appendix A, or Appendix B.

2.    Notice of Material Breach and Intent to Exclude. The parties agree that a material breach of this CIA by Envision constitutes an independent basis for Envision’s exclusion from participation in the Federal health care programs. The length of the exclusion shall be in the OIG’s discretion, but not more than five years per material breach. Upon a determination by OIG that Envision has materially breached this CIA and that exclusion is the appropriate remedy, OIG shall notify Envision of: (a) Envision’s material breach; and (b) OIG’s intent to exercise its contractual right to impose exclusion. (This notification shall be referred to as the “Notice of Material Breach and Intent to Exclude.”)
3.    Opportunity to Cure. Envision shall have 30 days from the date of receipt of the Notice of Material Breach and Intent to Exclude to demonstrate that:
		
	a.
	the alleged material breach has been cured; or

		
	b.
	the alleged material breach cannot be cured within the 30-day period, but that: (i) Envision has begun to take action to cure the material breach; (ii) Envision is pursuing such action with due diligence; and (iii) Envision has provided to OIG a reasonable timetable for curing the material breach.

4.    Exclusion Letter. If, at the conclusion of the 30-day period, Envision fails to satisfy the requirements of Section X.D.3, OIG may exclude Envision

Envision Corporate Integrity Agreement 33

from participation in the Federal health care programs. OIG shall notify Envision in writing of its determination to exclude Envision. (This letter shall be referred to as the “Exclusion Letter.”) Subject to the Dispute Resolution provisions in Section X.E, below, the exclusion shall go into effect 30 days after the date of Envision’s receipt of the Exclusion Letter. The exclusion shall have national effect. Reinstatement to program participation is not automatic. At the end of the period of exclusion, Envision may apply for reinstatement by submitting a written request for reinstatement in accordance with the provisions at 42 C.F.R. §§ 1001.3001-.3004.
E.    Dispute Resolution
1.Review Rights. Upon OIG’s delivery to Envision of its Demand Letter or of its Exclusion Letter, and as an agreed-upon contractual remedy for the resolution of disputes arising under this CIA, Envision shall be afforded certain review rights comparable to the ones that are provided in 42 U.S.C. § 1320a-7(f) and 42 C.F.R. Part 1005 as if they applied to the Stipulated Penalties or exclusion sought pursuant to this CIA. Specifically, OIG’s determination to demand payment of Stipulated Penalties or to seek exclusion shall be subject to review by an HHS ALJ and, in the event of an appeal, the HHS Departmental Appeals Board (DAB), in a manner consistent with the provisions in 42 C.F.R. § 1005.2-1005.21. Notwithstanding the language in 42 C.F.R. § 1005.2(c), the request for a hearing involving Stipulated Penalties shall be made within 10 days after receipt of the Demand Letter and the request for a hearing involving exclusion shall be made within 25 days after receipt of the Exclusion Letter. The procedures relating to the filing of a request for a hearing can be found at http://www.hhs.gov/dab/divisions/civil/procedures/divisionprocedures.html. 
2.Stipulated Penalties Review. Notwithstanding any provision of Title 42 of the United States Code or Title 42 of the Code of Federal Regulations, the only issues in a proceeding for Stipulated Penalties under this CIA shall be: (a) whether Envision was in full and timely compliance with the obligations of this CIA for which OIG demands payment; and (b) the period of noncompliance. Envision shall have the burden of proving its full and timely compliance and the steps taken to cure the noncompliance, if any. OIG shall not have the right to appeal to the DAB an adverse ALJ decision related to Stipulated Penalties. If the ALJ agrees with OIG with regard to a finding of a breach of this CIA and orders Envision to pay Stipulated Penalties, such Stipulated Penalties shall become due and payable 20 days after the ALJ issues such a decision unless Envision requests review of the ALJ decision by the DAB. If the ALJ decision is properly appealed to the DAB and the DAB upholds the determination of

Envision Corporate Integrity Agreement 34

OIG, the Stipulated Penalties shall become due and payable 20 days after the DAB issues its decision.
3.    Exclusion Review. Notwithstanding any provision of Title 42 of the United States Code or Title 42 of the Code of Federal Regulations, the only issues in a proceeding for exclusion based on a material breach of this CIA shall be whether Envision was in material breach of this CIA and, if so, whether:
		
	a.
	Envision cured such breach within 30 days of its receipt of the Notice of Material Breach; or

		
	b.
	the alleged material breach could not have been cured within the 30 day period, but that, during the 30 day period following Envision’s receipt of the Notice of Material Breach: (i) Envision had begun to take action to cure the material breach; (ii) Envision pursued such action with due diligence; and (iii) Envision provided to OIG a reasonable timetable for curing the material breach.

For purposes of the exclusion herein, exclusion shall take effect only after an ALJ decision favorable to OIG, or, if the ALJ rules for Envision, only after a DAB decision in favor of OIG. Envision’s election of its contractual right to appeal to the DAB shall not abrogate OIG’s authority to exclude Envision upon the issuance of an ALJ’s decision in favor of OIG. If the ALJ sustains the determination of OIG and determines that exclusion is authorized, such exclusion shall take effect 20 days after the ALJ issues such a decision, notwithstanding that Envision may request review of the ALJ decision by the DAB. If the DAB finds in favor of OIG after an ALJ decision adverse to OIG, the exclusion shall take effect 20 days after the DAB decision. Envision shall waive its right to any notice of such an exclusion if a decision upholding the exclusion is rendered by the ALJ or DAB. If the DAB finds in favor of Envision, Envision shall be reinstated effective on the date of the original exclusion.
4.    Finality of Decision. The review by an ALJ or DAB provided for above shall not be considered to be an appeal right arising under any statutes or regulations. Consequently, the parties to this CIA agree that the DAB’s decision (or the ALJ’s decision if not appealed) shall be considered final for all purposes under this CIA.
XI.    EFFECTIVE AND BINDING AGREEMENT

Envision Corporate Integrity Agreement 35

Envision and OIG agree as follows:
A.This CIA shall become final and binding on the date the final signature is obtained on the CIA.
B.This CIA constitutes the complete agreement between the parties and may not be amended except by written consent of the parties to this CIA.
C.OIG may agree to a suspension of Envision’s obligations under this CIA based on a certification by Envision that it is no longer providing health care items or services that will be billed to any Federal health care program and it does not have any ownership or control interest, as defined in 42 U.S.C. §1320a-3, in any entity that bills any Federal health care program. If Envision is relieved of its CIA obligations, Envision shall be required to notify OIG in writing at least 30 days in advance if Envision plans to resume providing health care items or services that are billed to any Federal health care program or to obtain an ownership or control interest in any entity that bills any Federal health care program. At such time, OIG shall evaluate whether the CIA will be reactivated or modified.
D.All requirements and remedies set forth in this CIA are in addition to and do not affect (1) Envision’s responsibility to follow all applicable Federal health care program requirements or (2) the government’s right to impose appropriate remedies for failure to follow applicable Federal health care program requirements.
E.The undersigned Envision signatories represent and warrant that they are authorized to execute this CIA. The undersigned OIG signatories represent that they are signing this CIA in their official capacities and that they are authorized to execute this CIA.
F.This CIA may be executed in counterparts, each of which constitutes an original and all of which constitute one and the same CIA. Facsimiles of signatures shall constitute acceptable, binding signatures for purposes of this CIA.

Envision Corporate Integrity Agreement 36

ON BEHALF OF ENVISION

	
			
	/s/ Craig Wilson
	 
	December 19, 2017

	Craig Wilson
	 
	DATE

	General Counsel
	 
	 

	 
	 
	 

	 
	 
	 

	/s/ Ross Ronan
	 
	December 19, 2017

	Ross Ronan
	 
	DATE

	Chief Compliance Officer
	 
	 

	 
	 
	 

	 
	 
	 

	/s/ David Matyas
	 
	December 19, 2017

	David Matyas
	 
	DATE

	Epstein Becker & Green, P.C.
	 
	 

	Counsel to Envision, Inc.
	 
	 

Envision Corporate Integrity Agreement 37

ON BEHALF OF THE OFFICE OF INSPECTOR GENERAL  
OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES

	
			
	/s/ Lisa M. Re
	 
	December 15, 2017

	LISA M. RE
	 
	DATE

	Assistant Inspector General for Legal Affairs
	 
	 

	Office of Inspector General
	 
	 

	U.S. Department of Health and Human Services
	 
	 

	 
	 
	 

	 
	 
	 

	/s/ Sandra Jean Sands
	 
	December 15, 2017

	SANDRA JEAN SANDS
	 
	DATE

	Senior Counsel
	 
	 

	Office of Inspector General
	 
	 

	U.S. Department of Health and Human Services
	 
	 

Envision Corporate Integrity Agreement 38

APPENDIX A

LEGAL INDEPENDENT REVIEW ORGANIZATION

This Appendix contains the requirements relating to the Legal Independent Review Organization (Legal IRO) required by Section III.E of the CIA.

A.    Legal IRO Engagement

1.Envision shall engage a Legal IRO that possesses the qualifications set forth in Paragraph B, below, to perform the responsibilities in Paragraph C, below. The Legal IRO shall not have a prohibited relationship to Envision, as set forth in Paragraph D. Within 30 days after OIG receives the information identified in Section V.A.9 of the CIA or any additional information submitted by Envision in response to a request by OIG, whichever is later, OIG will notify Envision if the Legal IRO is unacceptable. Absent notification from OIG that the Legal IRO is unacceptable, Envision may continue to engage the Legal IRO.
2.If Envision engages a new Legal IRO during the term of the CIA, that Legal IRO must also meet the requirements of this Appendix. If a new Legal IRO is engaged, Envision shall submit the information identified in Section V.A.9 of the CIA to OIG within 30 days of engagement of the Legal IRO. Within 30 days after OIG receives this information or any additional information submitted by Envision at the request of OIG, whichever is later, OIG will notify Envision if the Legal IRO is unacceptable. Absent notification from OIG that the Legal IRO is unacceptable, Envision may continue to engage the Legal IRO.

		
	B.
	Legal IRO Qualifications  

The Legal IRO shall:
1.be a law firm or individual with a legal degree;
2.assign individuals to conduct the Focus Arrangements Review who are knowledgeable about and have expertise in applying the requirements of the Anti-Kickback Statute and the regulations and other guidance documents related to this statute; and
3.possess expertise in fair market valuation issues or have the ability to associate a valuation firm to assist in conducting the transactions review component of the Focus Arrangements Review; and

	
			
	Envision Corporate Integrity Agreement
	1
	 

	Appendix A
	 
	 

4.    have sufficient staff and resources to conduct the reviews required by the CIA on a timely basis.

		
	C.
	Legal IRO Responsibilities 

The Legal IRO shall:
1.perform each Focus Arrangements Review in accordance with the specific requirements of the CIA;
2.respond to all OIG inquires in a prompt, objective, and factual manner; and
3.prepare timely, clear, well-written reports that include all the information required by Appendix B to the CIA.
D.    Legal IRO Relationship to Envision 
The entity that Envision selects to serve as the Legal IRO shall not:
		
	1.
	have previously represented or been employed or engaged by Envision; or

		
	2.
	have a relationship to Envision or its employees, officers, or directors that would cause a reasonable person to question the Legal IRO’s impartiality.

E.    Assertions of Privilege
Envision shall not assert claims of attorney-client privilege in order to avoid disclosing to OIG information related to or resulting from the Legal IRO’s engagement. Envision’s engagement letter with the Legal IRO shall include a provision stating that the Legal IRO agrees not to assert claims of work product privilege in order to avoid disclosing to OIG information related to or resulting from its engagement.
F.    Legal IRO Removal/Termination
1.Envision and Legal IRO. If Envision terminates its Legal IRO or if the Legal IRO withdraws from the engagement during the term of the CIA, Envision must submit a notice explaining (a) its reasons for termination of the Legal IRO or (b) the Legal IRO’s reasons for its withdrawal to OIG, no later than 30 days after termination or withdrawal. Envision must engage a new Legal IRO in accordance with Paragraph A of this Appendix and within 60 days of termination or withdrawal of the Legal IRO.
2.OIG Removal of Legal IRO. In the event OIG has reason to believe that the Legal IRO does not possess the qualifications described in Paragraph B, has a

	
			
	Envision Corporate Integrity Agreement
	2
	 

	Appendix A
	 
	 

relationship to Envision prohibited under Paragraph D, or has failed to carry out its responsibilities as described in Paragraph C, OIG shall notify Envision in writing regarding OIG’s basis for determining that the Legal IRO has not met the requirements of this Appendix. Envision shall have 30 days from the date of OIG’s written notice to provide information regarding the Legal IRO’s qualifications, independence or performance of its responsibilities in order to resolve the concerns identified by OIG. If, following OIG’s review of any information provided by Envision regarding the Legal IRO, OIG determines that the Legal IRO has not met the requirements of this Appendix, OIG shall notify Envision in writing that Envision shall be required to engage a new Legal IRO in accordance with Paragraph A of this Appendix. Envision must engage a new Legal IRO within 60 days of its receipt of OIG’s written notice. The final determination as to whether or not to require Envision to engage a new Legal IRO shall be made at the sole discretion of OIG.

	
			
	Envision Corporate Integrity Agreement
	3
	 

	Appendix A
	 
	 

APPENDIX B

FOCUS ARRANGEMENTS REVIEW

The Focus Arrangements Review shall consist of two components: a systems review and a transactions review. The Legal IRO shall perform all components of each Focus Arrangements Review. If there are no material changes to Envision’s systems, processes, policies, and procedures relating to Focus Arrangements, the Focus Arrangements Systems Review shall be performed for the first, second and fourth Reporting Periods. If Envision materially changes the Focus Arrangements systems, processes, policies and procedures, the Legal IRO shall perform a Focus Arrangements Systems Review for the Reporting Period in which such changes were made in addition to conducting the systems review for the first, second and fourth Reporting Periods. The Focus Arrangements Transactions Review shall be performed annually and shall cover each of the five Reporting Periods.

A.    Focus Arrangements Systems Review. The Focus Arrangements Systems Review shall be a review of Envision’s systems, processes, policies, and procedures relating to the initiation, review, approval, and tracking of Focus Arrangements. Specifically, the Legal IRO shall review the following:

1.Envision’s systems, policies, processes, and procedures with respect to creating and maintaining a centralized tracking system for all existing and new and renewed Focus Arrangements (Focus Arrangements Tracking System), including a detailed description of the information captured in the Focus Arrangements Tracking System;

2.Envision’s systems, policies, processes, and procedures for tracking remuneration to and from all parties to Focus Arrangements;

3.Envision’s systems, policies, processes, and procedures for tracking service and activity logs to ensure that parties to the Focus Arrangement are performing the services required under the applicable Focus Arrangement(s) (if applicable);

4.Envision’s systems, policies, processes, and procedures for monitoring the use of leased space, medical supplies, medical devices, equipment, or other patient care items to ensure that such use is consistent with the terms of the applicable Focus Arrangement(s) (if applicable);

5.Envision’s systems, policies, processes, and procedures for initiating Focus Arrangements, including those policies that identify the individuals with

	
			
	Envision Corporate Integrity Agreement
	1
	 

	Appendix B
	 
	 

authority to initiate a Focus Arrangement and that specify the business need or business rationale required to initiate a Focus Arrangement;

1.Envision’s systems, policies, processes, and procedures for the internal review and approval of all Focus Arrangements, including those policies that identify the individuals required to approve each type or category of Focus Arrangement entered into by Envision, the internal controls designed to ensure that all required approvals are obtained, and the processes for ensuring that all Focus Arrangements are subject to a legal review by counsel with expertise in the Anti-Kickback Statute;

2.the Compliance Officer’s annual review of and reporting to the Compliance Committee on the Focus Arrangements Tracking System, Envision’s internal review and approval process, and other Arrangements systems, process, policies, and procedures;

3.Envision’s systems, policies, processes, and procedures for implementing effective responses when suspected violations of the Anti-Kickback Statute are discovered, including disclosing Reportable Events and quantifying and repaying Overpayments when appropriate; and

4.Envision’s systems, policies, processes, and procedures for ensuring that all new and renewed Focus Arrangements comply with the Focus Arrangements Requirements set forth in Section III.D.2 of the CIA.

B.    Focus Arrangements Systems Review Report. The Legal IRO shall prepare a report based upon each Focus Arrangements Systems Review performed. The Focus Arrangements Systems Review Report shall include the following information:

1.a description of the documentation (including policies) reviewed and personnel interviewed;

2.a detailed description of Envision’s systems, policies, processes, and procedures relating to the items identified in Section A.1-9 above;

3.findings and supporting rationale regarding weaknesses in Envision’s systems, processes, policies, and procedures relating to Focus Arrangements described in Section A.1-9 above; and

4.recommendations to improve Envision’s systems, policies,
processes, or procedures relating to Focus Arrangements described in Section A.1-9 above.

	
			
	Envision Corporate Integrity Agreement
	2
	 

	Appendix B
	 
	 

C.    Focus Arrangements Transactions Review. The Focus Arrangements Transactions Review shall consist of a review by the Legal IRO of all Focus Arrangements at 40 hospitals, selected by OIG, where Envision has any Focus Arrangement to supply services to emergency departments or the services of a hospitalist that was in effect, entered into, or renewed by Envision during the Reporting Period. (Each selected hospital shall be referred to as a “Focus Arrangements Review Hospital”.)  The Legal IRO shall assess whether Envision has complied with the Focus Arrangements Procedures and the Focus Arrangements Requirements described in Sections III.D.1 and III.D.2 of the CIA, with respect to the Focus Arrangements between Envision and each Focus Arrangements Review Hospital.

The Legal IRO’s assessment with respect to each Focus Arrangement that is subject to review shall include:

1.verifying that the Focus Arrangement is maintained in Envision’s centralized tracking system in a manner that permits the Legal IRO to identify the parties to the Focus Arrangement and the relevant terms of the Focus Arrangement (i.e., the items/services/equipment/space to be provided, the amount of compensation, the effective date, the expiration date, etc.);

2.verifying that the Focus Arrangement was subject to the internal review and approval process (including both a legal and business review) and obtained the necessary approvals and that such review and approval is appropriately documented;

3.verifying that the remuneration related to the Focus Arrangement is properly documented and supported by a sound fair market valuation methodology; (if applicable) 

4.verifying that the Focus Arrangement is supported by a valid and properly documented business need or business rationale;

5.verifying that the remuneration related to the Focus Arrangement is properly tracked; (if applicable)

6.verifying that the service and activity logs are properly completed and reviewed by Envision, and that the parties to the Focus Arrangement are performing the services required under the applicable Focus Arrangement (if applicable);

7.verifying that the use of leased space, medical supplies, medical devices, and equipment, and other patient care items are properly monitored by Envision, and that such use is consistent with the terms of the applicable Focus Arrangement (if applicable);

	
			
	Envision Corporate Integrity Agreement
	3
	 

	Appendix B
	 
	 

8.verifying that the Focus Arrangement satisfies the Focus Arrangements Requirements of Section III.D.2 of the CIA; and

9.verifying that Envision’s Arrangements with Covered Persons at the Focused Arrangements Review Hospital do not violate theAnti-Kickback Statute which shall include:
		
	a.
	Envision furnishing the Legal IRO with a list of all Covered Persons who have provided services on behalf of Envision at the Focus Arrangements Review Hospital during the Reporting Period;

		
	b.
	Envision furnishing the Legal IRO with documentation reflecting the remuneration paid to all Covered Persons who have provided services on behalf of Envision at the Focus Arrangements Review Hospital; and

		
	c.
	The Legal IRO conducting interviews of Covered Persons who provide services on behalf of Envision at the Focus

Arrangements Review hospital.

D.    Focus Arrangements Transaction Review Report. The Legal IRO shall prepare a report based on each Focus Arrangements Transactions Review performed. The Focus Arrangements Transaction Review Report shall include the following information:

1.    Review Methodology.

		
	a.
	Review Protocol. A detailed narrative description of the procedures performed and a description of the sampling unit and universe utilized in performing the procedures for the sample reviewed.

		
	b.
	Sources of Data. A full description of the documentation and other information, if applicable, relied upon by the Legal IRO in performing the Focus Arrangements Transaction Review.

		
	c.
	Supplemental Materials. The Legal IRO shall request all documentation and materials required for its review of the Focus Arrangements selected as part of the Focus Arrangements Transaction Review and Envision shall furnish such documentation and materials to the Legal IRO prior to the Legal IRO initiating its review of the Focus

Arrangements. If the Legal IRO accepts any supplemental documentation or materials from Envision after the Legal IRO has completed its initial review of the Focus 

	
			
	Envision Corporate Integrity Agreement
	4
	 

	Appendix B
	 
	 

Arrangements (Supplemental Materials), the Legal IRO shall identify in the Focus Arrangements Transaction Review Report the Supplemental Materials, the date the Supplemental Materials were accepted, and the relative weight the Legal IRO gave to the Supplemental Materials in its review. In addition, the Legal IRO shall include a narrative in the Focus Arrangements Transaction Review Report describing the process by which the Supplemental Materials were accepted and the Legal IRO’s reasons for accepting the Supplemental Materials.

2.    Review Findings. The Focus Arrangements Transaction Review Report shall include the Legal IRO’s findings with respect to each of the items set forth in Section C.1-8, above. In addition, the Legal IRO shall identify in the Focus Arrangements Transactions Review Report any Arrangements with Covered Persons who provide services on behalf of Envision at the Focus Arrangements Review Hospital that a reasonable person would consider a probable violation of the Anti-Kickback Statute, along with the Legal IRO’s basis for reaching that conclusion.

The Focus Arrangements Transactions Review Report also shall include observations, findings and recommendations on possible improvements to Envision’s systems, policies, processed, and procedures in place to ensure that all Focus Arrangements comply with the Focus Arrangements Procedures and Focus Arrangements Requirements.

	
			
	Envision Corporate Integrity Agreement
	5
	 

	Appendix BASSET
PURCHASE AGREEMENT

This
Asset Purchase Agreement (this "Agreement") is made and entered into as of this 13th day of December, 2017 (the
"Effective Date"), by and among Nodechain, Inc, a Delaware corporation ("Purchaser"), Mewe World,
Inc., a California corporation ("Seller")

Recitals:

 

		A.	Seller
                                         warrants to Purchaser that he is the owner of the entire right, title,
                                         and interest in 5
                                         (“Units”) cryptocurrency
                                         mining rigs. Seller owns and operates cryptocurrency mining business that, among
                                         other things, cryptocurrency mining is the underlying system that allows Bitcoin, Ethereum
                                         and other cryptocurrencies to be traded in a decentralized manner. It revolves around
                                         a ledger, or database, that is continuously updated and accessible to the public. Nodes,
                                         have a copy of the ledger and verify the transactions by completing difficult mathematical
                                         problems. These validators are called "miners." They authenticate and group
                                         transactions into cryptographically protected "blocks" which are then added
                                         to the public "chain". Cryptocurrency miners are slowly rewarded with Bitcoin
                                         or Ethereum for carrying out this work, which requires substantial computing power. (collectively,
                                         the "Acquired Assets").

B. The Seller
wishes to sell and transfer, and the Purchaser wishes to purchase, the Seller’s right, title and interest in the forgoing
Patent Rights and other property described in Article I.

 

 

NOW, THEREFORE, the SELLER
and PURCHASER hereby agree as follows:

 

ARTICLE
I

Purchase
and Sale of Acquired Assets, Sale Free and Clear, Purchase Price

 

1.1 Purchase
and Sale of Acquired Assets. Upon the terms and subject to the conditions and provisions contained herein, at the Closing
(as defined in Section 2.1), the Seller shall sell, convey, assign and deliver to the Purchaser, and the Purchaser shall acquire
and accept from the Seller, free and clear of any and all liens, claims, interests and encumbrances, the Seller's right, title
and interest in and to the following assets of the Purchaser ("Acquired Assets"):

(a)
all tangible and intangible personal property relating to the foregoing 5 cryptocurrency mining rigs including but not limited
to any or existing inventory (“Units”) held by Seller;

1.2 Purchase
is Free and Clear. The Seller shall sell and transfer the Acquired Assets free and clear of all liens, claims, interests
and encumbrances asserted against the Acquired Assets, with such liens, claims, interests and encumbrances attaching to the proceeds
of the sale of the Acquired Assets, if any.

AGREEMENT

B.
The Seller wishes to sell and transfer, and the Purchaser wishes to purchase, the Seller’s right, title and interest in
the forgoing Patent Rights and other property described in Article I.

 

NOW, THEREFORE, the SELLER
and PURCHASER hereby agree as follows:

 

 

ARTICLE
I

 

Purchase
and Sale of Acquired Assets, Sale Free and Clear, Purchase Price

 

1.1 Purchase
and Sale of Acquired Assets. Upon the terms and subject to the conditions and provisions contained herein, at the Closing
(as defined in Section 2.1), the Seller shall sell, convey, assign and deliver to the Purchaser, and the Purchaser shall acquire
and accept from the Seller, free and clear of any and all liens, claims, interests and encumbrances, the Seller's right, title
and interest in and to the following assets of the Purchaser ("Acquired Assets"):

(a)
all tangible and intangible personal property relating to the foregoing in 5
(“Units”) cryptocurrency mining rigs and or existing inventory
(“Units”) held by Seller;

1.2 Purchase
is Free and Clear. The Seller shall sell and transfer the Acquired Assets free and clear of all liens, claims, interests
and encumbrances asserted against the Acquired Assets, with such liens, claims, interests and encumbrances attaching to the proceeds
of the sale of the Acquired Assets, if any.

1.3 Liabilities
Not Assumed. Notwithstanding anything to the contrary in this Agreement, the parties expressly acknowledge and agree that
the Purchaser shall not assume, be obligated to pay, perform or otherwise discharge or in any other manner be liable or responsible
for any liabilities, whether existing on the date of the Closing or arising thereafter as a result of any act, omission or circumstances
taking place prior to the Closing. Without limiting the foregoing, the Purchaser shall not be obligated to assume, and does not
assume, and hereby disclaims all liabilities of the Seller, or of any predecessor of any of the Seller, whether incurred or accrued
before or after the Effective Date or the Closing including but not limited to taxes, environmental issues, legal or accounting
services, employee benefit plans, employee obligations, any debts whether secured or unsecured, and all other liabilities of any
nature.

1.4 Purchase
Price. The Purchaser agrees to pay a total purchase price (the "Purchase Price") of FIVE HUNDRED DOLLARS
and 00/100 ($500.00) in cash as consideration of the sale and transfer of the Acquired Assets.

ARTICLE
II

The
Closing

 

2.1 Closing.
A closing shall take place at 5445 Oceanus Drive STE 102, Huntington Beach, CA 92649 on December 13th, 2017 at
a mutually agreed upon time unless the sale is postponed by the parties, (the "Closing").

 

	 	2.2	Conveyances
    at Closing

 

(a)        At
the Closing, in connection with effecting and consummating the transactions contemplated hereby, the Seller shall, to the extent
necessary to deliver title, in the Purchaser’s reasonable discretion, deliver the following to the Buyer:

(i)                an
executed Bill of Sale;

(ii)            such
other instruments as shall be reasonably requested by the Purchaser to vest in the Purchaser title in and to the Acquired Assets
in accordance with the provisions hereof and the order approving the sale.

 

(b)      At
the Closing, and in connection with effectuating and consummating the transactions contemplated hereby, the Purchaser shall deliver
the Purchase Price to the Seller in the form of a cashier or bank check.

  

(c)       The
form of any document to be delivered hereunder shall be in a form and substance and shall be executed and delivered in a manner
reasonable satisfactory to the Purchaser and Seller.

 

ARTICLE
III

 

Purchaser
Representations and Warranties

 

Purchaser
hereby represents and warrants to the Purchaser as follows:

 

3.1
Authority. The Purchaser represents and warrants that: (a) it has the necessary power and authority to execute and
deliver this Agreement and to perform the respective obligations hereunder; (b) this Agreement had been duly and validly delivered,
and constitutes a legal, valid and binding obligation; and no authorization consent, approval or other action is or will be necessary
as a condition to execution and delivery of this Agreement and the performance of the obligations hereunder.

 

Seller’s
Representations and Warranties

 

Seller hereby represents and warrants to the Purchaser as follows:

 

3.2 Authority.
The Seller represents and warrants that: (a) he has the necessary power and authority to execute and deliver this Agreement and
to perform the respective obligations hereunder; (b) this Agreement had been duly and validly delivered, and constitutes a legal,
valid and binding obligation; and no authorization consent, approval or other action is or will be necessary as a condition to
execution and delivery of this Agreement including, without limitation, the assignment of the Patent Rights to Purchaser and the
performance of the obligations hereunder. Seller has obtained any third party consents required to transfer assets, approvals,
and/or other authorizations required to enter into this Agreement and to carry out his obligations hereunder.

    

3.3 Enforcement: Seller has not put a third party on notice of actual or potential infringement of any of the
Patents or the Abandoned Assets. Seller has not invited any third party to enter into a license under any of the Patents or the Abandoned Assets.

 

3.4 No
third party licensee(s): Seller represents and warrants that there are no licenses
outstanding relating to the
foregoing 5 cryptocurrency mining rigs (“Units”) to
or by any third parties.

 

4. REPRESENTATIONS AND WARRANTIES OF BUYER.
Buyer hereby represents and warrants to Seller as follows:

4.1 Authority.
Purchaser is a corporation duly organized and existing under the laws of the State of California and is authorized to transact
business therein. Buyer has full power and authority to enter into, deliver and perform this Agreement. Buyer’s execution,
delivery and performance of, and the consummation of the transactions contemplated by, this Agreement have been duly authorized
by Buyer’s board of directors and shareholders. This Agreement constitutes the legal, valid, and binding obligation of Purchaser,
enforceable in accordance with its terms.

4.2 Encumbrances.
Purchaser represents and warrants that the funds it uses to pay the Purchase Price are not the subject of an Internal
Revenue Service lien or a lien of any other taxing authority.

4.3 Condition
of Assets. Buyer acknowledges that it is purchasing the assets listed on Exhibit “A” “As Is Where
Is”, with no warranties or representation as to condition.

 

5.0 General
Provisions

 

5.1 Limitation
of Liability: EXCEPT IN THE EVENT OF BREACH OF ANY OF THE WARRANTIES IN THE ABOVE SECTIONS, SELLER’S TOTAL LIABILITY UNDER
THIS AGREEMENT WILL NOT EXCEED THE PURCHASE PRICE. PURCHASER’STOTAL LIABILITY UNDER
THIS AGREEMENT WILL NOT EXCEED THE PURCHASE PRICE. THE PARTIES ACKNOWLEDGE THAT THE LIMITATIONS ON POTENTIAL LIABILITIES SET FORTH IN THIS
SECTION 6.1 WERE AN ESSENTIALELEMENT IN SETTING CONSIDERATION UNDER
THIS AGREEMENT.

 

5.2 Limitation
on Consequential Damages: EXCEPT IN THE EVENT OF BREACH OF ANY OF THE WARRANTIES IN THE ABOVE SECTIONS NEITHER PARTY WILL
HAVE ANY OBLIGATION OR LIABILITY (WHETHER IN CONTRACT, WARRANTY, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, AND NOTWITHSTANDING
ANY FAULT, NEGLIGENCE (WHETHER ACTIVE, PASSIVE OR IMPUTED), REPRESENTATION, STRICT LIABILITY OR PRODUCT LIABILITY), FOR COVER
OR FOR ANY INCIDENTAL, INDIRECT OR CONSEQUENTIAL, MULTIPLIED, PUNITIVE, SPECIAL, OR EXEMPLARY DAMAGES OR LOSS OF REVENUE, PROFIT,
SAVINGS OR BUSINESS ARISING FROM OR OTHERWISE RELATED TO THE LETTER AGREEMENT, EVEN IF A PARTY OR ITS REPRESENTATIVES HAVE BEEN
ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. THE PARTIES ACKNOWLEDGE THAT THESE EXCLUSIONS OF POTENTIAL DAMAGES WERE AN ESSENTIAL
ELEMENT IN SETTING CONSIDERATION UNDER THIS AGREEMENT.

 

5.3 Compliance
with Laws: Notwithstanding anything contained in this Agreement to the contrary, the obligations of the Parties with respect to the consummation of the transactions contemplated by this
Agreement shall be
subject to all laws, present and future, of anygovernment having jurisdiction over the Parties and this transaction, and to orders, regulations, directions or requests of any such government.

 

5.4 Confidentiality
of Terms: The Parties hereto will keep the terms of this Agreement confidential and will not now but may hereafter divulge
any of this information to the public after the closing has been completed.

 

5.5 Notices:
All notices given hereunder will be given in writing (in English or with an English translation), and will be delivered to the
address set forth on the signature page to this Agreement by personal delivery or delivery postage prepaid by an internationally-recognized
express courier service. Notices are deemed given on the date of receipt if delivered personally or by express courier, or if
delivery refused, the date of refusal. Notice given in any other manner will be deemed to have been given only if and when received
at the address of the Party to be notified. Either Party may from time to time change its address for notices under this Agreement
by giving the other Party written notice of such change.

5.6 Relationship
of Parties: Nothing in this Agreement will be construed to create a partnership, joint venture, franchise, fiduciary,
employment or agency relationship between the Parties. Neither Party has any express or implied authority to assume or create
any obligations on behalf of the other or to bind the other to any contract, agreement or undertaking with any third party.

5.7 Severability:
If any provision of this Agreement is found to be invalid or unenforceable, then the remainder of this Agreement will have full
force and effect, and the invalid provision will be modified, or partially enforced, to the maximum extent permitted to effectuate
the original objective.

5.8 Waiver:
Failure by either Party to enforce any term of this Agreement will not be deemed a waiver of future enforcement of that or any
other term in this Agreement or any other agreement that may be in place between the Parties.

5.9 Governing
Law: This Agreement will be interpreted, construed, and enforced in all respects in accordance with the laws of the State
of Rhode Island, without reference to its choice of law principles.

6.0 Entire
Agreement: The Agreement, including its exhibits, constitutes the entire agreement between the Parties with respect to
the subject matter hereof, and merges and supersedes all prior and contemporaneous agreements, understandings, negotiations, and
discussions. Neither of the Parties will be bound by any conditions, definitions, warranties, understandings, or representations
with respect to the subject matter hereof other than as expressly provided herein. No oral explanation or oral information by
either Party hereto will alter the meaning or interpretation of this Agreement. The terms and conditions of this Agreement will
prevail notwithstanding any different, conflicting or additional terms and conditions that may appear on any letter, email or
other communication or other writing not expressly incorporated into this Agreement.

6.1 Amendments:
No amendments or modifications will be effective unless in writing signed by authorized representatives of both Parties.

6.2 Headings:
The section headings contained in this Agreement are for reference purposes only and will not affect in any way the meaning or
interpretation of this Agreement.

6.3 No Rights
in Third Parties: The Agreement is not intended to confer any right or benefit on any third party (including, but not
limited to, any employee or beneficiary of any Party), and no action may be commenced or prosecuted against a Party by any third
party claiming as a third- party beneficiary of this Agreement or any of the transactions contemplated by this Agreement.

6.4 Counterparts:
This Agreement shall become binding when any one or more counterparts hereof, individually or taken together, shall bear the signatures
each of the Parties hereto. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original
as against the Party whose signature appears thereon, but all of which taken together shall constitute but one and the same instrument.

 

 

 

 

 

 

 

IN WITNESS WHEREOF, the Parties
have entered into this Agreement as of the Effective Date.

 

The Purchaser and Seller
hereby agree to the terms set forth above.

 

 

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Effective Date.

	SELLER:	 	PURCHASER:
	Mewe World, Inc., a
        California corporation

         

         

        By: /s/ Alham Benyameen

         

               Alham
        Benyameen, President and CEO

         
	 	Nodechain, Inc. a Delaware
        corporation

         

        By: /s/ Andy Michael
        Ibrahim

         

              Andy
        Michael Ibrahim, President and CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00277-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00277-of-00352.parquet"}]]